Search Results - "Menekse, Serkan"

Relationship between brain metastasis and thyroid transcription factor 1 by Kut, Engin, Menekşe, Serkan

“…Brain metastases (BMs) are common in lung adenocarcinomas (ACs). Thyroid transcription factor 1 (TTF-1) is important in the diagnosis of AC. This study aimed…”
Get full text

Prognostic significance of pretreatment albumin–bilirubin (ALBI) grade and platelet–albumin–bilirubin (PALBI) grade in patients with small cell lung cancer by Kut, Engin, Menekse, Serkan

“…Small cell lung cancer (SCLC) is a common cancer among the world’s lung cancers. Despite advances in diagnosis and treatment, the prognosis is still poor…”
Get full text

Survival outcomes and prognostic nutritional index in very elderly small-cell lung cancer patients: importance of active treatment and nutritional support by Almuradova, Elvina, Menekse, Serkan

“…BackgroundSmall-cell lung cancer (SCLC) is a highly aggressive tumor with a high metastatic potential, particularly affecting current or former heavy smokers…”
Get full text

Retrospective Evaluation of Fulvestrant Efficacy and Clinical Results in Patients Using Fulvestrant by Kut, Engin, Menekse, Serkan

“…Fulvestrant is a drug used in the treatment of metastatic hormone receptor-positive breast cancer (mHRPBC). Although clinical trials have shown the efficacy of…”
Get full text

The recurrence with isolated intra-abdominal lymph node in patients with colorectal cancer: A study of the Turkish Descriptive Oncological Researches Group (intra-abdominal lymph node and colon cancer) by Tanriverdi, Ozgur, Yilmaz, Eyup Murat, Menekse, Serkan, Cokmert, Suna, Oktay, Esin, Pilanci, Kezban Nur, Kocar, Muharrem, Avci, Nilufer, Akman, Tulay, Goksel, Gamze, Meydan, Nezih, Barutca, Sabri

“…This study aimed to identify the risk factors related in recurrence with isolated intra-abdominal lymph node metastasis in patients with colorectal cancer…”
Get full text

Pretreatment Serum Albumin Level is an Independent Prognostic Factor in Patients with Stage IIIB Non-Small Cell Lung Cancer: A Study of the Turkish Descriptive Oncological Researches Group by Tanriverdi, Ozgur, Avci, Nilufer, Oktay, Esin, Kalemci, Serdar, Pilanci, Kezban Nur, Cokmert, Suna, Menekse, Serkan, Kocar, Muharrem, Sen, Cenk Ahmet, Akman, Tulay, Ordu, Cetin, Goksel, Gamze, Meydan, Nezih, Barutca, Sabri

“…Background: Several prognostic factors have been studied in NSCLC, although it is unknown which is most useful. In this study, we aimed to investigate whether…”
Get full text

Adult Urological Soft Tissue Sarcomas: A Multicenter Study of the Anatolian Society of Medical Oncology (ASMO) by Unal, Olcun Umit, Oztop, Ilhan, Menekse, Serkan, Urakci, Zuhat, Bozkurt, Oktay, Ozcelik, Melike, Gunaydin, Yusuf, Yasar, Nurgul, Yazilitas, Dogan, Kodaz, Hilmi, Taskoylu, Burcu Yapar, Aksoy, Asude, Demirci, Umut, Araz, Murat, Tonyali, Onder, Sevinc, Alper, Yilmaz, Ahmet Ugur, Benekli, Mustafa

“…Objective: To analyze clinicopathological characteristics, prognostic factors and survival rates of the patients with urological soft tissue sarcomas treated…”
Get full text

Efficacy of adjuvant capecitabine in residual triple negative breast cancer: a multicenter observational Turkish Oncology Group (TOG) study by Taşçı, Elif Şenocak, Kutlu, Yasin, Ölmez, Ömer Fatih, Mutlu, Arda Ulaş, Gündoğdu, Yasemin, Seyyar, Mustafa, Şahin, Elif, Çabuk, Devrim, Majidova, Nargiz, Uğurlu, İrem, Demirci, Ayşe, Aydın, Dinçer, Çavdar, Eyyüp, Bayram, Selami, Yıldırım, Nilgün, Karataş, Fatih, Eryılmaz, Melek Karakurt, Çağlayan, Dilek, Menekşe, Serkan, Kut, Engin, Arak, Hacı, Keser, Murat, Sunar, Veli, Perkin, Perihan, Şakalar, Teoman, Oyan, Başak, Sönmez, Özlem, Özer, Leyla, Yıldız, İbrahim

“…Triple negative breast cancer (TNBC) is characterized by high rates of recurrence, especially in patients with residual disease after neoadjuvant chemotherapy…”
Get more information

XELOX Plus Bevacizumab vs. FOLFIRI Plus Bevacizumab Treatment for First-line Chemotherapy in Metastatic Colon Cancer: a Retrospective Study of the Anatolian Society of Medical Oncology by Duran, Ayse Ocak, Karaca, Halit, Besiroglu, Mehmet, Bayoglu, Ibrahim Vedat, Menekse, Serkan, Yapici, Heves Surmeli, Yazilitas, Dogan, Bahceci, Aykut, Uysal, Mukremin, Sevinc, Alper, Hacibekiroglu, Ilhan, Aksoy, Asude, Tanriverdi, Ozgur, Arpaci, Erkan, Inanc, Mevlude, Dane, Faysal, Ozkan, Metin

“…Background: XELOX plus bevacizumab (XELOX-Bev) and FOLFIRI plus Bevacizumab (FOLFIRI - Bev) treatments are an effective strategies patients with metastatic…”
Get full text

Efficacy and tolerability of current treatments for hormone-refractory prostate cancer patients with visceral metastases by Oruç, Zeynep, Kaplan, M Ali, Karaağaç, Mustafa, Özyurt, Neslihan, Tatlı, Ali Murat, Kaya, Ali Osman, Menekşe, Serkan, Kut, Engin, Koca, Sinan, Sever, Özlem Nuray, Yasin, İrem, Ebinç, Senar, Zeynelgil, Esra, Sakin, Abdullah, Turhal, Nazım Serdar, Isikdogan, Abdurrahman

“…To assess the efficacy and tolerability of the first-line treatment options for hormone-refractory prostate cancer patients with visceral metastases. The…”
Get full text

The Relationship Between KRAS Mutation and 18F-FDG Uptake Parameters in Colorectal Cancer by Özen, Aynur, Menekşe, Serkan, Namal, Esat, Kahraman Akkalp, Aslı, Tokoçin, Merve, Vartanoğlu, Talar, Gökmen, Emel, Çelebi, Fatih

“…Objective: Our purpose in this study was to evaluate whether Kirsten rat sarcoma viral oncogene (KRAS) exon-2 mutation affected 18F-fluorodeoxyglucose (FDG)…”
Get full text

Demographical and Clinical Features of Marginal Zone Lymphomas: A Retrospective Study of Turkish Oncology Group (TOG) by Türkkan, Görkem, Alkan, Ali, Paydaş, Semra, Tanrıverdi, Özgür, Karakaş, Yusuf, Karadurmuş, Nuri, Sakin, Abdullah, Temiz, Süleyman, Arpacı, Erkan, Akın, Mustafa, Menekşe, Serkan, Şen, Cenk Ahmet, Barışta, İbrahim

“…Marginal zone lymphomas (MZLs) are rare and indolent subtypes of non-Hodgkin lymphomas, and their clinical behaviours are heterogeneous. The aim of this study…”
Get full text

First-line treatment of patients with HER2-positive metastatic gastric and gastroesophageal junction cancer by Esen, Selin Akturk, Ergun, Yakup, Erol, Cihan, Arikan, Rukiye, Er, Muhammed Muhiddin, Atci, Muhammed Mustafa, Topcu, Atakan, Ucar, Gokhan, Akagunduz, Baran, Aykan, Musa Baris, Ozen, Mirac, Baytemur, Naziyet Kose, Ozcelik, Melike, Sahin, Elif, Guven, Denizcan, Menekse, Serkan, Ak, Naziye, Teker, Fatih, Kut, Engin, Sakalar, Teoman, Alan, Ozkan, Kacan, Turgut, Turhal, Nazim Serdar, Kilickap, Saadettin, Turker, Sema, Sendur, Mehmet Ali Nahit, Kostek, Osman, Karaagac, Mustafa, Sakin, Abdullah, Turk, Haci Mehmet, Caglayan, Dilek, Cihan, Sener, Acikgoz, Yusuf, Uncu, Dogan

“…Fluoropyrimidine+cisplatin/oxaliplatin+trastuzumab therapy is recommended for the first-line treatment of human epidermal growth factor receptor 2…”
Get full text

Comparison of survival with somatostatin analog and chemotherapy and prognostic factors for treatment in 165 advanced neuroendocrine tumor patients with Ki-67 20% or less by Özaslan, Ersin, Karaca, Halit, Koca, Sinan, Sevinç, Alper, Hacioğlu, Bekir, Özkan, Metin, Özçelik, Melike, Duran, Ayşe O, Hacibekiroğlu, İlhan, Yildiz, Yaşar, Tanriverdi, Özgür, Menekşe, Serkan, Aksoy, Asude, Bozkurt, Oktay, Urvay, Semiha, Uysal, Mükremin, Demir, Hacer, Çiltaş, Aydin, Dane, Faysal

“…The objectives of this study were to compare progression-free survival (PFS) with somatostatin analog (SSA) versus chemotherapy (CTx) in first-line therapy and…”
Get full text

Predictive and Prognostic Factors in Ovarian and Uterine Carcinosarcomas by Cicin, İrfan, Özatlı, Tahsin, Türkmen, Esma, Özturk, Türkan, Özçelik, Melike, Çabuk, Devrim, Gökdurnalı, Ayşe, Balvan, Özlem, Yıldız, Yaşar, Şeker, Metin, Özdemir, Nuriye, Yapar, Burcu, Tanrıverdi, Özgür, Günaydin, Yusuf, Menekşe, Serkan, Öksüzoğlu, Berna, Aksoy, Asude, Erdogan, Bülent, Bekir Hacıoglu, M, Arpaci, Erkan, Sevinç, Alper

“…Prognostic factors and the standard treatment approach for gynaecological carcinosarcomas have not yet been clearly defined. Although carcinosarcomas are more…”
Get full text

Pazopanib in metastatic soft tissue sarcoma (STS): Results of a multi-institutional observational study by Bilici, Ahmet, Koca, Sinan, Karaagac, Mustafa, Eraslan, Emrah, Ocak, Birol, Goktas Aydin, Sabin, Sezgin Goksu, Sema, Paydas, Semra, Derin, Sumeyye, Ergun, Yakup, Yekegunduz, Emre, Erol, Cihan, Tataroglu Ozyukseler, Deniz, Demiray, Atike Gokcen, Karaca, Mustafa, Guc, Zeynep Gulsum, Menekse, Serkan, Yesil Cinkir, Havva, Gumusay, Ozge, Sakin, Abdullah

“…e23542 Background: Soft tissue sarcomas (STS) are a heterogenous group of tumors which have limited therapeutic options and poor prognosis in…”
Get full text

The effect of the gastrectomy on survival in patients with metastatic gastric cancer: a study of ASMO by Yaz c, Ozan, Özdemir, Nuriye, Duran, Ay e Ocak, Menek e, Serkan, Nahit endur, Mehmet Ali, Karaca, Halit, Göksel, Gamze, Arpac, Erkan, Hac bekiro lu, lhan, Bilgetekin, rem, Kaçan, Turgut, Özkan, Metin, Aksoy, Sercan, Aksoy, Asude, Çokmert, Suna, Uysal, Mükremin, Elk ran, Emin Tamer, Çiçin, rfan, Büyükberber, Süleyman, Zengin, Nurullah

“…To investigate the role of surgical resection of primary tumor on overall survival (OS) in advanced gastric cancer patients at the time of diagnosis. The…”
Get full text

Real-world outcomes of pazopanib in metastatic soft tissue sarcoma: a retrospective Turkish oncology group (TOG) study by Bilici, Ahmet, Koca, Sinan, Karaagac, Mustafa, Aydin, Sabin Goktas, Eraslan, Emrah, Kaplan, Muhammed Ali, Ocak, Birol, Goksu, Sema Sezgin, Paydas, Semra, Akgul, Fahri, Derin, Sumeyye, Ergun, Yakup, Yekeduz, Emre, Erol, Cihan, Ozyukseler, Deniz Tataroglu, Demiray, Atike Gokcen, Karaca, Mustafa, Guc, Zeynep Gulsum, Menekse, Serkan, Cinkir, Havva Yesil, Gumusay, Ozge, Sakin, Abdullah, Ozkul, Ozlem, Demir, Hacer, Erdem, Dilek, Besiroglu, Mehmet, Unal, Olcun Umit, Acar, Ramazan, Koral, Lokman, Sahin, Suleyman, Sakalar, Teoman, Bahceci, Aykut, Ozveren, Ahmet, Gunaydin, Ulug Mutlu, Seker, Mehmet Metin, Sunar, Veli, Dal, Pinar, Artac, Mehmet, Turhal, Serdar

“…Aim Description of patient characteristics, effectiveness and safety in Turkish patients treated with pazopanib for metastatic soft tissue sarcoma (STS)…”
Get full text

Real-Life Analysis of Efficacy and Safety of Everolimus Plus Exemestane in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor-2-Negative Metastatic Breast Cancer Patients: A Turkish Oncology Group (TOG) Study by Bilici, Ahmet, Uysal, Mukremin, Menekse, Serkan, Akin, Semih, Yildiz, Fatih, Turan, Merve, Sezgin Goksu, Sema, Beypinar, Ismail, Sakalar, Teoman, Değirmenci, Mustafa, Erdem, Dilek, Basaran, Gul, Olmez, Omer Fatih, Avci, Nilufer, Tural, Deniz, Sakin, Abdullah, Turker, Sema, Demir, Atakan, Temiz, Suleyman, Kaplan, Muhammed Ali, Dogan, Mutlu, Tanriverdi, Ozgur, Bilgetekin, Irem, Cinkir, Havva Yesil, Acikgoz, Ozgur, Paydas, Semra, Uslu, Ruchan, Turhal, Serdar

“…This study evaluated the efficacy and safety of everolimus (EVE) plus exemestane (EXE) in hormone-receptor positive (HR+), human epidermal growth factor…”
Get full text

Real-life comparison of afatinib and erlotinib in non-small cell lung cancer with rare EGFR exon 18 and exon 20 mutations: a Turkish Oncology Group (TOG) study by Gursoy, Pınar, Tatli, Ali Murat, Erdem, Dilek, Goker, Erdem, Celik, Emir, Demirci, Nebi Serkan, Sakin, Abdullah, Atci, Muhammed Mustafa, Bayram, Ertuğrul, Telli, Tuğba Akın, Bilgin, Burak, Bilici, Ahmet, Akangunduz, Baran, Balli, Sevinç, Demirkazik, Ahmet, Selçukbiricik, Fatih, Menekse, Serkan, Cavdar, Eyyüp, Ozturk, Akın, Bekmez, Esma Türkmen, Turhal, Serdal, Kilickap, Sadettin, Yildirim, Hasan Çağrı, Oyan, Başak, Aksoy, Asude, Turkoz, Fatma Paksoy, Kut, Engin, Katgi, Nuran, Sakalar, Teoman, Akyol, Murat, Ellez, Halil İbrahim, Topcu, Atakan, Erdoğan, Atike Pınar, Pilanci, Kezban Nur, Hedem, Engin, Arak, Hacı, Akdeniz, Nadiye, Alan, Özkan, Yapar, Burcu, Nart, Deniz, Yumuk, Perran Fulden

“…Objectives To compare the survival of first- and second-generation tyrosine kinase inhibitors (TKIs) in patients with rare EGFR exon 18 and exon 20…”
Get full text